Stereochemically enriched compositions for delivery of nucleic acids
AssigneeTranslate Bio, Inc.
InventorsFrank DeRosa, Shrirang Karve, Michael Heartlein
Life of this patent
Estimating the term…
Loading patent…
AssigneeTranslate Bio, Inc.
InventorsFrank DeRosa, Shrirang Karve, Michael Heartlein
Estimating the term…
Provided, in part, is a composition comprising one or more chemical entities of formula I, each of which is a compound of formula I: a pharmaceutically acceptable salt thereof, a solvate thereof, or a solvate of a pharmaceutically acceptable salt thereof, the composition characterized in that greater than a first threshold amount of the total amount of chemical entities of formula I in the composition: are chemical entities of formula I.a, wherein the first threshold amount is 50%; or are chemical entities of formula I.b.1, wherein the first threshold amount is 25%; or are chemical entities of formula I.b.2, wherein the first threshold amount is 25%, wherein the chemical entities of formula I.a, I.b.1, and I.b.2, are described herein, and methods of using such compositions, for example, for the delivery of a polynucleotide in vivo.
1-61. (canceled)
A composition comprising one or more chemical entities of formula I, each of which is a compound of formula I:
A method for treating a disease or disorder by delivery of an mRNA encoding a therapeutic protein, comprising administering to a subject in need of delivery a pharmaceutical composition comprising a lipid nanoparticle and a pharmaceutically acceptable excipient, wherein the lipid nanoparticle comprises:
Dependencies are inferred from the claim text.